![John Bradshaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Bradshaw
Directeur/Membre du Conseil chez
SYNAIRGEN PLC
Fortune : 266 141 $ au 30/06/2026
Profil
John Bradshaw is the founder of Crescendo Biologics Ltd., founded in 2007.
Mr. Bradshaw is also the founder of Eight19 Ltd...
Mr. Bradshaw is an Independent Non-Executive Director at Creo Medical Ltd. since 2013.
Mr. Bradshaw is a Director at Autifony SRL.
Mr. Bradshaw is a Director at Syncona Management LLP.
Mr. Bradshaw is a Director at Syncona Discovery Ltd. since 2017.
Mr. Bradshaw is an Independent Non-Executive Director at Synairgen Plc starting 2025.
Mr. Bradshaw is Co-Chief Financial Officer at Avillion LLP since 2014.
Mr. Bradshaw is an Advisor at Science Creates Ventures LLP.
Mr. Bradshaw was Senior Independent Non-Executive Director at Creo Medical Group Plc.
Mr. Bradshaw was Independent Non-Executive Director at Ixico Plc from 2013 to 2022.
Mr. Bradshaw was Chief Financial Officer & Director at TheraCryf Plc.
Mr. Bradshaw was Finance Director at Analysys Ltd. Mr. Bradshaw was Director at PneumaCare Ltd. Mr. Bradshaw was Director at TheraCryf Pharma Ltd. from 2015 to 2017.
Mr. Bradshaw was Chief Financial Officer & Director at TopiVert Ltd. Mr. Bradshaw was Director at Burrowmoor Consulting Ltd. from 2006 to 2012.
Mr. Bradshaw was Finance Director at Healthcare Executive Group.
Mr. Bradshaw was Chief Financial Officer at Gyrus Group Ltd. from 1997 to 2008.
Mr. Bradshaw was Chief Financial Officer at TeraView Ltd. Mr. Bradshaw was Chief Financial Officer at Plastic Logic, Inc. from 2006 to 2008.
Mr. Bradshaw was Principal at Arthur Andersen (UK) from 1986 to 1997.
Mr. Bradshaw was Chief Financial Officer at Nxera Pharma UK Ltd. from 2008 to 2015.
Mr. Bradshaw was Chief Financial Officer at GlySure Ltd. Mr. Bradshaw was Chief Financial Officer at Syncona Partners LLP.
Mr. Bradshaw was Partner at Bradshaw Daniel Ltd. from 2012 to 2020.
Mr. Bradshaw was Chief Financial Officer at Syncona Investment Management Ltd. from 2016 to 2021.
Mr. Bradshaw completed undergraduate studies at The University of Liverpool in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CREO MEDICAL GROUP PLC 0,31 % | 31/12/2024 | 1 371 082 ( 0,31 % ) | 266 141 $ | 30/06/2026 |
Postes actifs de John Bradshaw
| Sociétés | Poste | Début |
|---|---|---|
| SYNAIRGEN PLC | Directeur/Membre du Conseil | 01/05/2025 |
Science Creates Ventures
 Science Creates Ventures Investment ManagersFinance Science Creates Ventures invests in companies located in the United Kingdom. The firm focuses on the technology sector. It provides capital for seed and early stage capital requirements. | Consultant / Advisor | - |
Syncona Discovery Ltd.
 Syncona Discovery Ltd. Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | 17/01/2017 |
Syncona Management LLP | Directeur/Membre du Conseil | - |
Autifony SRL
 Autifony SRL BiotechnologyHealth Technology Operates as a biotechnology that develops new medicines | Directeur/Membre du Conseil | - |
Avillion LLP
 Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Directeur Financier/CFO | - |
Creo Medical Ltd.
 Creo Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes medical device technologies | Directeur/Membre du Conseil | - |
Anciens postes connus de John Bradshaw
| Sociétés | Poste | Fin |
|---|---|---|
| CREO MEDICAL GROUP PLC | Directeur/Membre du Conseil | 22/05/2025 |
| IXICO PLC | Directeur/Membre du Conseil | 30/04/2022 |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de John Bradshaw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
Ixico Plc
 Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
Gyrus Group Ltd.
 Gyrus Group Ltd. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets electro-surgical systems | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TeraView Ltd.
 TeraView Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures terahertz imaging and spectroscopic devices | Electronic Technology |
Analysys Ltd.
 Analysys Ltd. Miscellaneous Commercial ServicesCommercial Services Provides consulting services in the strategy, management and IT fields | Commercial Services |
Plastic Logic, Inc.
 Plastic Logic, Inc. Packaged SoftwareTechnology Services Develops plastic electronic technology solutions | Technology Services |
Arthur Andersen (UK)
 Arthur Andersen (UK) Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
GlySure Ltd.
 GlySure Ltd. Medical SpecialtiesHealth Technology Develops glucose monitoring devices | Health Technology |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
PneumaCare Ltd.
 PneumaCare Ltd. Electronic Equipment/InstrumentsElectronic Technology Designs and develops respiratory diagnostic and monitoring equipment | Electronic Technology |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease | Health Services |
Eight19 Ltd.
 Eight19 Ltd. Electric UtilitiesUtilities Manufactures high performance solar cells | Utilities |
TopiVert Ltd.
 TopiVert Ltd. BiotechnologyHealth Technology Provides treatments for inflammatory diseases of the eye and gut | Health Technology |
Creo Medical Ltd.
Creo Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes medical device technologies | Electronic Technology |
Avillion LLP
Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Health Technology |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Burrowmoor Consulting Ltd. | |
Autifony SRL
Autifony SRL BiotechnologyHealth Technology Operates as a biotechnology that develops new medicines | Health Technology |
Bradshaw Daniel Ltd.
 Bradshaw Daniel Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and bookkeeping services | Commercial Services |
Healthcare Executive Group
 Healthcare Executive Group Internet Software/ServicesTechnology Services Operates as a healthcare executives, thought leaders and industry professional platform | Technology Services |
Syncona Management LLP | |
Creo Medical Group Plc
 Creo Medical Group Plc Medical SpecialtiesHealth Technology Develops CROMA electrosurgical platform | Health Technology |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona aims to build a sustainable, diverse portfolio of 15-20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which they are seeking to deliver strong risk-adjusted returns for shareholders. The firm takes a long-term view, underpinned by a strategic capital base which enables them to maintain significant ownership positions in their companies and provides them with control and flexibility over the management of their portfolio. | Finance |
Syncona Discovery Ltd.
Syncona Discovery Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Science Creates Ventures
Science Creates Ventures Investment ManagersFinance Science Creates Ventures invests in companies located in the United Kingdom. The firm focuses on the technology sector. It provides capital for seed and early stage capital requirements. | Finance |
Choisissez Zonebourse 
